AKKARAJU SRINIVAS
Director · ALUMIS INC.
Every open-market stock purchase AKKARAJU SRINIVAS has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.
Where the buys stand today
- ALMSALUMIS INC.
21 purchases totalling $31.3M at an average of $9.90 per share. See all insider buying in ALMS →
Avg price paid$9.90Latest price—Market capUnknown - MLYS+49.8% vs price paidMineralys Therapeutics, Inc.
2 purchases totalling $23.1M at an average of $19.44 per share; the stock last traded at $29.12. See all insider buying in MLYS →
Avg price paid$19.44Latest price$29.12Market cap$2.6B - SRRKScholar Rock Holding Corp
9 purchases totalling $20.0M at an average of $37.71 per share. See all insider buying in SRRK →
Avg price paid$37.71Latest price—Market capUnknown - NGNENeurogene Inc.
3 purchases totalling $1.2M at an average of $25.76 per share. See all insider buying in NGNE →
Avg price paid$25.76Latest price—Market cap$535.4M - KLRSKalaris Therapeutics, Inc.
One purchase totalling $1.2M at an average of $4.83 per share. See all insider buying in KLRS →
Avg price paid$4.83Latest price—Market capUnknown
Cluster participation
Buys that landed within days of other insiders buying the same stock — the pattern this site exists to catch.
All reported buys
| Date | Ticker | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | 273,290 | $10.63 | $2.9M | SEC ↗ | |
| Sep 8, 2026 | 273,291 | $10.63 | $2.9M | SEC ↗ | |
| Sep 4, 2026 | 220,070 | $11.17 | $2.5M | SEC ↗ | |
| Sep 4, 2026 | 220,070 | $11.17 | $2.5M | SEC ↗ | |
| May 20, 2026 | 244,300 | $4.83 | $1.2M | SEC ↗ | |
| Jan 9, 2026 | ALMScluster | 588,235 | $17.00 | $10.0M | SEC ↗ |
| Dec 5, 2025 | ALMScluster | 51,380 | $10.73 | $551.3K | SEC ↗ |
| Dec 5, 2025 | ALMScluster | 70,028 | $10.01 | $701.0K | SEC ↗ |
| Dec 5, 2025 | ALMScluster | 64,969 | $8.95 | $581.5K | SEC ↗ |
| Dec 4, 2025 | ALMScluster | 66,027 | $8.18 | $540.1K | SEC ↗ |
| Dec 3, 2025 | ALMScluster | 100,000 | $7.75 | $775.0K | SEC ↗ |
| Dec 2, 2025 | ALMScluster | 96,000 | $7.55 | $724.8K | SEC ↗ |
| Dec 1, 2025 | ALMScluster | 86,350 | $7.46 | $644.2K | SEC ↗ |
| Nov 28, 2025 | ALMScluster | 38,702 | $7.64 | $295.7K | SEC ↗ |
| Nov 26, 2025 | ALMScluster | 48,537 | $7.64 | $370.8K | SEC ↗ |
| Nov 20, 2025 | ALMScluster | 125,743 | $7.20 | $905.3K | SEC ↗ |
| Nov 19, 2025 | ALMScluster | 137,772 | $6.56 | $903.8K | SEC ↗ |
| Nov 18, 2025 | ALMScluster | 102,652 | $6.05 | $621.0K | SEC ↗ |
| Nov 13, 2025 | ALMScluster | 276,179 | $5.25 | $1.4M | SEC ↗ |
| Oct 7, 2025 | 12,400 | $40.18 | $498.2K | SEC ↗ | |
| Oct 7, 2025 | 12,796 | $39.31 | $503.0K | SEC ↗ | |
| Oct 7, 2025 | 4,403 | $40.97 | $180.4K | SEC ↗ | |
| Oct 6, 2025 | 80,863 | $38.68 | $3.1M | SEC ↗ | |
| Oct 6, 2025 | 18,414 | $37.89 | $697.7K | SEC ↗ | |
| Oct 6, 2025 | 13,748 | $39.52 | $543.3K | SEC ↗ | |
| Oct 3, 2025 | 319,700 | $37.42 | $12.0M | SEC ↗ | |
| Oct 3, 2025 | 56,703 | $36.74 | $2.1M | SEC ↗ | |
| Oct 3, 2025 | 11,011 | $35.61 | $392.1K | SEC ↗ | |
| Sep 4, 2025 | MLYScluster | 588,235 | $25.50 | $15.0M | SEC ↗ |
| May 5, 2025 | ALMScluster | 138,368 | $4.58 | $633.7K | SEC ↗ |
| May 5, 2025 | ALMScluster | 22,002 | $5.27 | $116.0K | SEC ↗ |
| May 2, 2025 | ALMScluster | 159,920 | $4.55 | $727.6K | SEC ↗ |
| Mar 13, 2025 | MLYScluster | 600,000 | $13.50 | $8.1M | SEC ↗ |
| Nov 26, 2024 | NGNEcluster | 10,803 | $26.01 | $281.0K | SEC ↗ |
| Nov 26, 2024 | NGNEcluster | 20,748 | $24.91 | $516.8K | SEC ↗ |
| Nov 26, 2024 | NGNEcluster | 15,219 | $26.73 | $406.8K | SEC ↗ |
Get alerted the next time AKKARAJU SRINIVAS — or any insider — buys
We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.
About this data
Figures are parsed from AKKARAJU SRINIVAS's Form 4 filings on SEC EDGAR (CIK 1253170) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.